Kimbell & Associates

What Kimbell & Associates does

Jeffrey J. Kimbell & Associates, Inc. is a privately held, boutique government affairs and health policy consulting firm founded in 1998 by Jeffrey J. Kimbell and headquartered in Washington, DC, with additional offices in Park City, UT and Nashville, TN. The 21-person firm delivers strategic legislative, regulatory, policy, and advocacy solutions to more than 75-85 enterprise clients in the life sciences community, spanning biopharmaceutical, medical device, biotechnology, cell and gene therapy, and healthcare technology companies. Engagements span federal representation before Congress, CMS, HHS, and key health policy stakeholders, including work on IRA implementation, MDUFA, the 21st Century Cures Act, and gene therapy reimbursement.

The firm operates through five integrated service lines: Government Affairs, Health Policy & Reimbursement, PAC Services, Communications & Public Affairs, and Health Technology & Artificial Intelligence (a newer practice established around 2020 and reinforced by 2025 senior hires). There is no proprietary technology platform; the offering is people-based professional services delivered by senior advisors and former Congressional and Administration officials. The firm monetizes through professional services fees (quote-based, not publicly disclosed) derived from enterprise consulting engagements and long-cycle retainer relationships. The go-to-market motion is direct enterprise engagement, supplemented by leadership's industry speaking presence and a LinkedIn corporate channel.

Competitive positioning is built on bipartisan relationships cultivated since 1998 with Members of Congress, agency officials, and health policy stakeholders; the firm's leadership roster includes former HELP and Energy & Commerce committee staff, former Trump HHS officials, and the founding MDMA executive director. The firm maintains deep operational ties to advocacy ecosystems through leadership roles at the Institute for Gene Therapies, and coordination with trade associations including MDMA, AdvaMed, and the Claim Your Health Data Coalition. The company is founder-controlled, privately held, with no disclosed institutional investors or parent company.

Name

Kimbell & Associates

Legal name

Jeffrey J. Kimbell & Associates, Inc.

Website

https://kimbell-associates.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Jeffrey J. Kimbell & Associates is a 21-person Washington, DC-based boutique government affairs and health policy consulting firm serving 75-85+ enterprise life sciences clients across biopharma, medical device, cell/gene therapy, and health technology through five integrated practice lines.

Ownership category

akta.pro rank

Product category

Government Affairs & Health Policy Consulting

NAICS

Professional, Scientific, and Technical Services (541), Management Consulting Services (54161), Professional, Scientific, and Technical Services (54)

SIC

Services-Management Services (8741)

akta.pro primary industry

Policy, Regulatory & Public Affairs Research (BPAHALAF)

Keywords

• Government affairs consulting
• Health policy advisory
• Legislative advocacy services
• PAC consulting services
• Life sciences policy

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Government Affairs & Policy Consulting Services: Professional consulting fees for strategic legislative, regulatory, policy, and advocacy solutions provided to life sciences clients. Services include government affairs, health policy, PAC services, communications & public affairs, and health technology & AI policy guidance.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Jeffrey J. Kimbell & Associates, Inc. is a boutique professional services firm that delivers strategic legislative, regulatory, policy, and communications solutions to life sciences companies. The firm is organized across five service lines — Government Affairs, Health Policy & Reimbursement, PAC Services, Communications & Public Affairs, and Health Technology & Artificial Intelligence — that collectively help biopharmaceutical, medical device, biotechnology, and healthcare technology clients navigate Washington, shape public discourse, and influence federal policy outcomes.

Product overview

Jeffrey J. Kimbell & Associates is a professional services and consulting firm that provides strategic legislative, regulatory, policy, and communications solutions to clients in the life sciences community. The firm operates as a unified consulting practice organized across five interconnected service lines: Government Affairs, Health Policy & Reimbursement, PAC Services, Communications & Public Affairs, and Health Technology & Artificial Intelligence. These practice areas work in concert to help clients navigate complex policy environments in Washington, shape public discourse, advance policy objectives, and achieve their business goals.

Differentiator

Problem solved

Functional benefit

Products and services

• Government Affairs Legislative and regulatory advocacy services that help life sciences clients build relationships with federal officials, shape legislation, and navigate Washington policy processes before Congress, federal agencies, and key health policy stakeholders.
• Health Policy & Reimbursement Strategic advising on federal healthcare programs including Medicare, Medicaid, 340B, and TRICARE, with expertise in coverage, coding, and payment issues for healthcare technology, biopharmaceutical, medical device, biotech, and cell and gene therapy clients.
• PAC Services Political Action Committee consulting services including PAC launch support, membership expansion, and gross receipt solicitation for life sciences companies.
• Communications & Public Affairs Integrated communications and public affairs services including policy narrative development, corporate reputation management, issues and risk communications, and stakeholder engagement for life sciences clients.
• Health Technology & Artificial Intelligence Policy guidance and advocacy services focused on AI regulation in healthcare, drug development AI, software as a medical device, clinical decision support tools, interoperability, health data privacy, and cybersecurity.

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• Institute for Gene Therapies (IGT)coreStrategic or Co-development Partner · 1 January 2020Kimbell & Associates staff serve in leadership roles for IGT, a non-profit advocacy organization launched in 2020 to help address coverage, access, and reimbursement challenges surrounding gene therapies. Katherine Sistrunk serves as Manager of Health Policy and Advocacy for IGT, Kenny Hodge serves as Director of Government Affairs for IGT, and John Feore serves as Director of Health Policy and Advocacy for IGT.
• Medical Device Manufacturers Association (MDMA)coreImplementation/ SI/ Consulting PartnerDavid Rudloff works in coordination with MDMA representing pharmaceutical and medical device clients. The firm has extensive experience working with trade associations including MDMA on issues such as Medical Device User Fee Amendments (MDUFA) and the National Defense Authorization Act (NDAA).
• Advanced Medical Technology Association (AdvaMed)coreImplementation/ SI/ Consulting PartnerDavid Rudloff works in coordination with AdvaMed representing medical device clients. The firm has extensive experience advocating on behalf of medical technology manufacturers on diverse policy issues.
• EveryLife Foundation for Rare DiseasesminorStrategic or Co-development PartnerAllison Itz gained policy experience through her work with the EveryLife Foundation for Rare Diseases before joining Kimbell & Associates, representing rare disease patient advocacy interests.
• Claim Your Health Data CoalitionminorStrategic or Co-development PartnerJohn R. Ray serves as Executive Director of the Claim Your Health Data Coalition, demonstrating the firm's involvement in coalition-based advocacy efforts.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Sidley Austin LLP: Global law firm with a top healthcare and life sciences regulatory practice — competes for the same clients on FDA, CMS, and Congressional matters (Lauren Buckley previously worked there).
• Faegre Drinker: National law firm with a significant healthcare regulatory and government affairs practice, serving large life sciences and medical device clients.
• Covington & Burling: Premier DC-based law firm with deep FDA, healthcare regulatory, and public policy practices; serves many of the same life sciences clients across regulatory and legislative matters.
• Akin Gump Strauss Hauer & Feld: Large international law firm with one of the most established healthcare/life sciences lobbying practices; competes for the same enterprise healthcare clients from a much broader full-service platform.

Direct peers

• Mehlman Consulting: Bipartisan government relations and strategic consulting firm focused on healthcare, tax, technology, and energy, with comparable senior lobbyist engagement model.
• BGR Group: Bipartisan boutique government affairs and public advocacy firm in Washington with strong healthcare practice and integrated public affairs — the closest direct competitor in size, business model, and life sciences focus to Kimbell.
• Avalere Health: Healthcare-focused consultancy providing policy, regulatory, and reimbursement advisory — overlaps heavily with Kimbell's Health Policy & Reimbursement practice and competes for similar biopharma/medical device engagements.
• Cornerstone Government Affairs: Boutique bipartisan government affairs firm covering healthcare, tax, and technology with similar senior-advisor-driven engagement model and life sciences clients.
• Forbes Tate Partners: Bipartisan government affairs and strategic consulting firm serving healthcare, life sciences, and technology clients; competes head-to-head for similar retainer-based advocacy and policy advisory work in DC.
• Manatt Health: Healthcare consulting and policy advisory practice within Manatt, providing strategic advice on federal healthcare programs, reimbursement, and life sciences policy — direct competitor for the same client mandates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/kimbell-&-associates

Revenue estimate

Valuation estimate

Number of profiles

Profiles22 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kimbell & Associates